A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL — Stella

Recruiting

Back to Follicular Lymphoma trials

Trial locations(1 site)

China

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~332 participants

Started

June 2023

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated June 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov